James Healy - Director at Rapport Therapeutics, Inc.

Issuer-level insider activity

Role: Director
Issuer ticker: RAPP on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by James Healy since 10 Sep 2025

Reported holdings for James Healy in Rapport Therapeutics, Inc.

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Common Stock
Shares / value: 1,863,327
Estimated value: $18,596,003
Report date: 01 Jul 2024
Price: $9.98
Ownership: By Sofinnova Venture Partners XI, L.P.

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Common Stock
Shares / value: 40,851
Estimated value: $407,693
Report date: 01 Jul 2024
Price: $9.98
Ownership: By Crestline Summit Master, SPC - PEAK SP

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Common Stock
Shares / value: 39,661
Estimated value: $395,817
Report date: 01 Jul 2024
Price: $9.98
Ownership: By CRESTLINE SUMMIT PINNACLE MASTER, L.P.

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Common Stock
Shares / value: 33,114
Estimated value: $330,478
Report date: 01 Jul 2024
Price: $9.98
Ownership: By Crestline Summit Master, SPC - CRESTLINE SUMMIT APEX SP

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Common Stock
Shares / value: 18,641
Estimated value: $186,037
Report date: 01 Jul 2024
Price: $9.98
Ownership: By Sofinnova Synergy Master Fund LP

Form 4 holding Director

Rapport Therapeutics, Inc.

Security class: Stock Option (Right to Buy)
Shares / value: 15,200
Estimated value
Report date: 10 Jun 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for James Healy in Rapport Therapeutics, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .